The Asia Pacific Mental Health Screening Market was valued at $172.8 Million in 2023 and projected to reach to $398.5 Million by 2028, representing a compound annual growth rate of 14.9%. The Asia Pacific mental health screening market is positioned for sustained growth through 2028, driven by demographic shifts, urbanization, and increasing prevalence of mental health disorders across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific's mental health screening market is valued at $172.8 million in 2023 and is projected to grow to $398.5 million by 2028, representing a robust 14.9% CAGR—outpacing the global average of 12.2%.
Expanding digital health infrastructure across Asia Pacific is enabling wider adoption of mental health screening tools, telemedicine platforms, and AI-driven diagnostic solutions in both urban and emerging markets.
Increasing awareness of mental health conditions, coupled with reduced stigma and government initiatives, is driving demand for screening services across China, Japan, India, and Southeast Asian nations.
Rising healthcare investments and government funding for mental health programs in Asia Pacific countries are accelerating the adoption of standardized screening protocols and clinical assessment tools.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | COGNITIVE (Application) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 12.2% from 2023 to 2028 |
| Largest Segment | ADULTS (AGE 19-64 YEARS) (Age Group) |
| Market Size Base Year (Billions) | ~USD 0.9 (2023) |
| Revenue Forecast (Billions) | ~USD 1.6 (2028) |
| Segments Covered | Application, Type, Screening Method, Technology, Age Group, Setting |
6 segment dimensions are covered across the global market.
| Country | 2025 size (native) |
|---|---|
| China | USD 50.72 Million |
| Japan | USD 56.79 Million |
| India | USD 37.84 Million |
| Rest Of Asia Pacific | USD 70.7 Million |
The Asia Pacific mental health screening market was valued at $172.8 million in 2023 and is projected to grow to $398.5 million by 2028.
Asia Pacific's mental health screening market is expected to grow at a compound annual growth rate (CAGR) of 14.9% from 2023 to 2028.
Key drivers include increasing mental health awareness, rising healthcare investments, expanding digital health infrastructure, workplace wellness programs, and school-based screening initiatives across Asia Pacific.
Asia Pacific's 14.9% CAGR significantly outpaces the global market CAGR of 12.2%, indicating stronger regional demand and adoption of mental health screening solutions.
Telemedicine platforms, digital screening tools, and mobile health applications are expanding access to mental health screening services across Asia Pacific, particularly in underserved areas.
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.
After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.
Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.
Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Mental Health Screening Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report